Claude J Spicher from the Université de Fribourg asked in a medical Forum (Research gate): Who is prescribing palmitoylethanolamide to CRPS patients ?
I am writing the 4th ed. of my Handbook for Somatosensory Rehabilitation of Neuropathic Pain. I am wondering if I should add a section about palmitoylethanolamide (PEA). What is your experience?
Dr Corrado Amedeo Presti from the’Azienda Sanitaria Provinciale di Ragusa’ said:
My experience is positive: allows to decrease the doses of other drugs (opioids, for example), it acts on neuroinflammation. As the molecule has still vast unexplored areas
Professor Maurizio Evangelista from the Catholic University of the Sacred Heart:
I use pea exstensively since 1995. My personal field of action is in Chronic not oncological pain. Let me know if you are interested for a paper about pea and this issue. With my best regard
Professor Jan M Keppel Hesselink from the Universität Witten/Herdecke:
Definitely, I have used it since 2010 in many patients suffering from chronic pain and CRPS, I also refer to the various formulations and fake PEA problems: https://palmitoylethanolamide4pain.com/the-truth-about-pea-palmitoylethanolamide-in-recent-formulations/